Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets
Harri Lempiäinen(Genedata (Switzerland)), Johan Björkegren(Karolinska University Hospital), Heribert Schunkert(German Centre for Cardiovascular Research), Matthias Prestel(Ludwig-Maximilians-Universität München), Thorsten Kessler(Deutsches Herzzentrum München), Hassan Foroughi Asl(Universität Hamburg), Lingyao Zeng(Queen Mary University of London), Ingrid Brænne(Universität Hamburg), Rainer Malik(Ludwig-Maximilians-Universität München), Oscar Franzén(Time Critical Networks (Sweden)), Hugh Watkins(John Radcliffe Hospital), Claudia Biegert(Genedata (Switzerland)), Gerard Pasterkamp(University Medical Center Utrecht), Folkert W. Asselbergs(Health Data Research UK), Stephen E. Hamby(University of Leicester), Timo Wittenberger(Genedata (Switzerland)), Husain A. Talukdar(Karolinska University Hospital), Philip Gribbon(Merck (Germany)), Sander W. van der Laan(Utrecht University), Theodosios Kyriakou(Centre for Human Genetics), Anuj Goel(Centre for Human Genetics), Martin Dichgans(Munich Cluster for Systems Neurology), Tom Michoel(Roslin Institute), Arno Ruusalepp(Tartu University Hospital), Tobias Dreker(Lead Discovery Center (Germany)), Tom R. Webb(NIHR Leicester Biomedical Research Centre), Vinicius Tragante(deCODE Genetics (Iceland)), Jeanette Erdmann(Universität Hamburg), Baiba Vilne(Riga Stradiņš University), Nilesh J. Samani(University of Leicester), Johannes Eichner(University of Tübingen), Christina Willenborg(School of the Art Institute of Chicago), Christine Schofield(Horizon Discovery (United Kingdom)), Mira Graettinger(Gesellschaft zur Förderung angewandter Informatik), Barbara Stiller(University of Cologne)
Cited by 48
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k